Format

Send to

Choose Destination
J Bone Miner Res. 2017 May;32(5):883-888. doi: 10.1002/jbmr.3086. Epub 2017 Feb 23.

CRISPR/CAS9 Technologies.

Author information

1
Center for Cancer and Cell Biology, Van Andel Research Institute, Grand Rapids, MI, USA.
2
Orthopaedic Research Laboratories, Boston Children's Hospital, Boston, MA, USA.

Abstract

The Clustered Regularly Interspaced Palindromic Repeats (CRISPR)/CRISPR-associated protein (Cas) pathway is revolutionizing biological research. Modifications to this primitive prokaryotic immune system now enable scientists to efficiently edit DNA or modulate gene expression in living eukaryotic cells and organisms. Thus, many laboratories can now perform important experiments that previously were considered scientifically risky or too costly. Here, we describe the components of the CRISPR/Cas system that have been engineered for use in eukaryotes. We also explain how this system can be used to genetically modify cell lines and model organisms, or regulate gene expression in order to search for new participants in biological pathways.

KEYWORDS:

ANIMAL MODELS; GENE EDITING; MOLECULAR BIOLOGY

PMID:
28230927
PMCID:
PMC5413371
DOI:
10.1002/jbmr.3086
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Wiley Icon for PubMed Central
Loading ...
Support Center